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Background. The lactogenic hormones prolactin (PRL) and placental lactogens (PL) play central roles in reproduction and
mammary development. Their actions are mediated via binding to PRL receptor (PRLR), highly expressed in brown adipose
tissue (BAT), yet their impact on adipocyte function and metabolism remains unclear. Methodology/Principal Findings. PRLR
knockout (KO) newborn mice were phenotypically characterized in terms of thermoregulation and their BAT differentiation
assayed for gene expression studies. Derived brown preadipocyte cell lines were established to evaluate the molecular
mechanisms involved in PRL signaling on BAT function. Here, we report that newborn mice lacking PRLR have hypotrophic BAT
depots that express low levels of adipocyte nuclear receptor PPARc2, its coactivator PGC-1a, uncoupling protein 1 (UCP1) and
the b3 adrenoceptor, reducing mouse viability during cold challenge. Immortalized PRLR KO preadipocytes fail to undergo
differentiation into mature adipocytes, a defect reversed by reintroduction of PRLR. That the effects of the lactogens in BAT are
at least partly mediated by Insulin-like Growth Factor-2 (IGF-2) is supported by: i) a striking reduction in BAT IGF-2 expression
in PRLR KO mice and in PRLR-deficient preadipocytes; ii) induction of cellular IGF-2 expression by PRL through JAK2/STAT5
pathway activation; and iii) reversal of defective differentiation in PRLR KO cells by exogenous IGF-2. Conclusions. Our
findings demonstrate that the lactogens act in concert with IGF-2 to control brown adipocyte differentiation and growth. Given
the prominent role of brown adipose tissue during the perinatal period, our results identified prolactin receptor signaling as a
major player and a potential therapeutic target in protecting newborn mammals against hypothermia.
Citation: Viengchareun S, Servel N, Fe `ve B, Freemark M, Lombe `s M, et al (2008) Prolactin Receptor Signaling Is Essential for Perinatal Brown Adipocyte
Function: A Role for Insulin-like Growth Factor-2. PLoS ONE 3(2): e1535. doi:10.1371/journal.pone.0001535
INTRODUCTION
The lactogenic hormones of the placenta (placental lactogens, PL)
and pituitary gland (prolactin, PRL) regulate a variety of
physiological processes involved in gonadal function and reproduc-
tion, mammary development and lactation, adrenal and pancreatic
hormone secretion, and intermediary metabolism [1]. In humans
and rodents, these actions are mediated via binding of lactogens to
the prolactin receptor (PRLR), a class I cytokine receptor linked to
activation of the JAK/STAT signaling pathway [2].
In postnatal rodents and ungulates, the PRLR and associated
STAT5 activity are detected in most tissues at various stages of
development [2,3]; in the fetus, on the other hand, PRLR emerge
during mid-late gestation [4–6], when high expression levels are
detected in the liver, lung, gastrointestinal tract, olfactory
epithelium, renal tubules, pancreatic beta cells, and brown adipose
tissue (BAT). The latter is of particular interest because BAT
mediates adaptive (nonshivering) thermogenesis [7], the process of
heat generation required for thermostabilization and survival
during delivery and the transition from intrauterine to extrauterine
life. The key effector of adaptive thermogenesis is uncoupling
protein 1 (UCP1), whose expression is restricted to BAT
mitochondria [8]. UCP1 dissipates the proton gradient at the
inner mitochondrial membrane to prevent oxidative phosphory-
lation, generating heat rather than ATP. A critical upstream
regulator of adaptive thermogenesis is peroxisome proliferator
gamma co-activator 1 alpha (PGC-1a), which promotes mito-
chondrial biogenesis [9].
Recent studies have elucidated the molecular mechanisms
controlling BAT development. The key transcriptional regulator
of adipogenesis in brown, as in white, adipose tissue is PPARc
[10]. Early in the course of adipocyte differentiation, C/EBPb and
d are expressed transiently and contribute to induction of PPARc
and C/EBPa, which is required to maintain PPARc expression.
C/EBPa also functions synergistically with PPARc to promote the
expression of genes found in both BAT and WAT [11] as well as
PGC-1a and UCP1, which are preferentially or exclusively
expressed in brown adipocytes.
The expression of BAT genes is regulated by a number of
hormones and growth factors including the thyroid hormones,
catecholamines, leptin, insulin, and insulin-like growth factor-1
(IGF-1). However, cold adaptation can be maintained in the
absence of thyroid hormones, and deletion of thyroid hormone
receptor a and b [12] or of b1, b2 and b3 adrenergic receptor
subtypes [13,14] has no effect on BAT PGC-1a mRNA or UCP1
protein levels under non-stressed conditions. Moreover, targeted
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PLoS ONE | www.plosone.org 1 February 2008 | Issue 2 | e1535deletion of the thyroid hormone receptors, the insulin receptor, or
insulin receptor substrates 1, 2, 3 or 4, which mediate many of the
metabolic effects of insulin and IGF-1, have no effects on BAT
mass in newborn mice [12,15–17]. These findings suggest that
other hormones or growth factors might contribute to BAT
growth and function during the fetal or perinatal periods.
Given their presence in fetal and postnatal plasma and their
binding to brown adipocytes in vivo and in vitro [4,5,18], we
hypothesized that the lactogenic hormones may play a physiolog-
ical role in the regulation of BAT development and thermogenesis
during the perinatal period. To test that hypothesis, we employed
three novel experimental models of lactogen action. The PRLR
knockout (KO) mouse [19], which cannot respond to either PL (in
utero) or PRL (perinatal and postnatal periods), was used to assess
the effects of lactogen resistance in vivo on BAT mass,
mitochondrial structure, gene expression, and the adaptation to
cold. These studies were performed on the day of birth to establish
their physiological relevance. Immortalized preadipocyte cell lines
derived from the interscapular brown adipose depots of PRLR
KO mice were employed to assess the direct effects of PRL
signaling on adipocyte differentiation and function in vitro and to
determine if reintroduction of PRLR can restore brown adipocyte
commitment. Finally, the PRL-responsive T37i cell line [18],
derived from a BAT hibernoma developed in a transgenic mouse
[20], was used to assess the molecular mechanisms by which
PRLR signaling controls BAT differentiation.
We discovered that absence of PRLR signaling compromised
the growth and differentiation of BAT in vivo and in vitro and
reduced plasma concentrations and BAT expression of insulin-like
growth factor-2 (IGF-2), which plays a central role in the control of
placental and fetal growth [21,22]. We therefore examined the
regulation of IGF-2 mRNA levels by PRL in isolated brown
adipocytes and the effects of IGF-2 on brown adipocyte
differentiation and growth; we then determined if exogenous
IGF-2 could reverse the effects of PRLR-deficiency on BAT
development in immortalized preadipocyte cell lines. Our findings
suggest that the lactogens act in concert with IGF-2 to control
brown adipocyte differentiation and growth.
RESULTS
Brown adipose tissue development is altered in
PRLR KO mice
The demonstration that prolactin receptors (PRLR) are expressed
at high levels in brown adipocytes of fetal and newborn rodents [5]
and are functional in brown adipocytes [18] led us to explore the
physiological relevance of PRL action in BAT in vivo. To that end,
we characterized BAT development in newborn PRLR KO mice
and their wild type (WT) littermates. The body weights of
newborn PRLR KO mice were not different from those of WT
pups; however the absolute interscapular BAT mass, evaluated by
its weight and the BAT/body weight ratio, was significantly
reduced in PRLR KO mice as compared with WT littermates
(Fig. 1A). These findings suggested that lactogens function as
growth factors in BAT during fetal development, since the
reduction in PRLR KO BAT mass was detected at birth.
To assess further the impact of PRLR deletion on BAT
development in vivo, we analyzed the histological appearance of
brown adipocytes in newborn PRLR KO and WT mice (Fig. 1B
and C). WT brown adipocytes were significantly larger than
PRLR KO cells; there was a 35% decrease in mean cell surface of
PRLR KO brown adipocytes (Fig. 1D), corresponding to a 50%
reduction of cell volume. To determine if the reduction in cell size
reflected a decrease in cellular lipids, we compared the triglyceride
content of PRLR KO BAT depots with that of WT depots.
Triglyceride content was decreased by 40% in the absence of
PRLR signaling, highlighting the importance of the lactogens in
brown adipocyte function (Fig. 1E). However, the activities of
citrate synthase (CS) and of glycerol-3 phosphate dehydrogenase
(G3PDH), one of the enzymatic steps of the tricarboxylic acid
cycle also implicated in the initiation of lipogenesis, did not differ
between WT and KO BAT homogenates (Supplemental data Fig.
S1 and Text S1). These observations suggest that the reduction of
triglyceride content in PRLR KO BAT results from a defect in
adipocyte differentiation rather than a defect in lipogenesis per se.
We next examined the expression of adipogenic markers in order
to evaluate the impact of PRLR on brown adipocyte differentiation
in vivo.P P A R c2 as well as SREBP1 expression in BAT were
decreased in PRLR KO mice, consistent with a compromised
adipocyte differentiation (Fig. 1F and G). In addition, there was a
striking reduction in PGC-1a mRNA levels. Since PGC-1a regulates
mitochondrial biogenesis and energy production through induction
of UCP1 expression and through functional interaction with
PPARc2 and the retinoic acid receptor (RXRa), the thermometa-
bolic capacity of PRLR KO mice was subsequently evaluated.
Alterations of thermogenesis and BAT mitochondria
in PRLR KO animals
To assess the effects of lactogen resistance (PRLR deletion) on
thermogenesis, we subjected newborn mice to a cold challenge and
calculated their survival rates during the 400-min period, since
alternative methods such as measurement of rectal temperature or
indirect calorimetry could not be performed on newborn animals.
Newborn PRLR KO pups were more sensitive to cold exposure
than their WT littermates; 50% mortality was observed at 125 and
200 min, in PRLR KO and WT mice, respectively, and 30% of
the WT mice, but none of the PRLR KO mice, survived more
than 300 min (Fig. 2A).
The key effector of adaptive thermogenesis and cold adaptation
is UCP1. To determine if UCP1 expression is altered in PRLR
KO animals, we quantified UCP1 expression in interscapular
BAT. Both UCP1 mRNA and protein levels were significantly
reduced in BAT of newborn PRLR KO mice (Fig. 2B, 2C),
suggesting that UCP1 deficiency accounts for their thermogenic
defect. Given the prominent role played by the b3 adrenoceptor
(b3Adr) in mediating catecholamines effects on thermogenesis in
rodents [23], b3Adr transcripts were quantified in WT and PRLR
KO neonates (Fig. 2D); its significant decrease strongly supports
the thermogenic defect, and therefore the physiological relevance
of PRLR signaling BAT function.
BAT differs from white fat by its high degree of vascularization
and mitochondrial density. Electron microscopic analysis of BAT
demonstrated striking differences in mitochondrial morphology of
PRLR KO mice compared to WT littermates (Fig. 2E). Smaller,
sparse and often elongated mitochondria were present in the
cytoplasm of PRLR KO brown adipocytes. This was associated
with reduced fat droplets, in accordance with morphological and
functional BAT abnormalities. Of note, the number of mitochon-
drial DNA copies in brown adipocytes of PRLR KO mice did not
differ from those in WT mice (supplemental data Fig. S2A).
Accordingly, cytochrome c oxidase (COX) activity, the fourth
complex of the respiratory chain selected as representative of the
mtDNA-dependent mitochondrial activities, did not vary between
KO and WT BAT (supplemental data Fig. S2B and Text S1).
Thus, the respiratory chain activity of lactogen-resistant brown
adipocytes was preserved while their thermogenic capacity was
clearly impaired. Taken together, these observations strongly
Prolactin and Brown Adipocytes
PLoS ONE | www.plosone.org 2 February 2008 | Issue 2 | e1535Figure 1. Lack of PRLR impaired brown adipose tissue development in newborns. A) Body weight (BW), BAT weight and BAT/BW ratio were
determined in newborn wild type (WT) and PRLR (KO) mice. The BAT weight and BAT/BW ratio were significantly lower in PRLR KO mice (n=16) than
in WT animals (n=15) (*p,0.05). Results represent mean6SE. B, C and D) Decreased brown adipocyte size in BAT of PRLR KO (C) compared to WT
mice (B). BAT of newborn animals were collected, fixed and stained with hematoxylin and eosin. Representative images are presented (objective660).
Adipocyte cell surface was calculated using the Lucia software and a significant decreased was detected in PRLR KO mice (n=5) vs controls (n=5)
(***p,0.001, n=200 cells /group). E) Intracellular triglyceride content of BAT was significantly reduced in PRLR KO mice (**p,0.01). F, G and H)
Drastic decrease of PPARc2, SREBP1 and PGC-1a mRNA expression in BAT of PRLR KO mice compared to control littermates. BAT of WT and PRLR KO
newborn mice were collected, total RNA extracted and processed for quantitative real time PCR analysis of gene expression as described in the
Materials and Methods section. Relative expression within a given sample was calculated as the ratio (attomol of specific gene/fmol of 18S). Results
are presented as mean6SE of 15–16 animals. * p,0.05 and ** p,0.01.
doi:10.1371/journal.pone.0001535.g001
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PLoS ONE | www.plosone.org 3 February 2008 | Issue 2 | e1535Figure 2. Alteration of thermogenesis in PRLR KO mice. A) PRLR KO newborn mice are more sensitive to cold exposure. Newborn animals were
maintained in a 4uC environment and their survival was measured as a function of time (min). Kaplan-Meier representation of survival rate of KO
(n=6) and WT (n=8) mice reveals a statistical difference (p,0.022). B) UCP1 mRNA expression in BAT of PRLR KO mice was significantly reduced
compared to WT littermates. Quantitative real time PCR analysis of UCP1 mRNA expression was performed as described above. Results, expressed as
attomol of UCP1/fmol of 18S, represent mean6SE of 15–16 animals (*** p,0.001). C) Western blot analysis of UCP1 expression in BAT of PRLR KO
compared to WT mice. BAT of newborn animals were collected, lysed and 2 mg of proteins from homogenates were processed for immunoblotting
with specific antibodies against UCP1 and ERK1/2. Quantification of UCP1 signal ratio was measured by densitometry using the Quantity One
software (Biorad) and a significant decreased was detected in PRLR KO mice vs controls (***p,0.001, n=6 per group). D) b3 adrenoceptor expression
in BAT of PRLR KO mice was significantly reduced compared to WT littermates. Results, expressed as attomol of b3AdR /fmol of 18S, represent
mean6SE of 15–16 animals (*p,0.05). E) Representative transmission electron-microscopic images of brown adipocytes of interscapular BAT from a
WT newborn mouse and PRLR KO littermate. WT brown adipocytes exhibited intracytoplasmic lipid vacuoles and numerous mitochondria. Note that
the mitochondria are extremely dense, compacted and characterized by their round shape and packed cristae encompassing the entire organelles
(see arrow). Virtually, no cytoplasmic compartment is visible. In contrast, mitochondria in PRLR KO brown adipocytes are smaller, less packed and
presented with elongated and fusiform features. The amount of cristae seems to be reduced (inset). Magnification X 15,000.
doi:10.1371/journal.pone.0001535.g002
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and/or maintenance of thermogenic function in BAT.
Differentiation of immortalized PRLR deficient
preadipocytes is impaired
To investigate whether PRLR deficiency limits the ability of
brown preadipocytes to undergo adipogenic conversion, we
isolated cells from the stromal vascular fraction of interscapular
BAT of PRLR KO and WT newborns. Several brown
preadipocyte cell lines were established after stable transfection
of the P1-TAg expression vector, which contains the immortal-
izing SV40 large T Antigen (TAg) under the control of the
proximal promoter of the human mineralocorticoid receptor gene.
This transgene was previously used to generate the T37i brown
adipocyte cell line [20] (Fig. 3A and B). The differentiation
capacities of PRLR KO and WT cell lines were assessed in order
to decipher the molecular events by which PRLR signaling
contributes to the commitment to the brown adipose phenotype.
Fig. 3C presents results obtained with representative clones of WT
and PRLR KO preadipocytes. At post confluence (day 0) both cell
lines exhibited fibroblast-like morphology and expressed the SV40
TAg, as demonstrated by its nuclear immunodetection (inset).
After 6 days of exposure to insulin and T3, the WT preadipocytes
differentiated and accumulated triglycerides within multilocular fat
droplets (Fig. 3C, upper panel). In contrast, PRLR KO
preadipocytes failed to accumulate cytoplasmic lipid droplets
(Fig. 3C, middle panel), suggesting that PRLR signaling plays a
crucial role in brown adipocyte differentiation. Similar results were
obtained in all other independent cell lines derived from PRLR
KO animals (data not shown).
To assess further the role of PRLR signaling in response to PRL
and PL which are present in the fetal calf serum, we stably
transfected a murine PRLR expression vector into PRLR KO
preadipocytes (KO+PRLR) and examined the adipogenic activa-
tion cascade. After 6 days exposure to the differentiation mixture
(insulin + T3), PRLR-rescued cells accumulated triglycerides and
acquired the morphologic appearance of mature brown adipocytes
(Fig. 3C, lower panel). RT-PCR analysis performed on WT,
PRLR KO and PRLR-rescued cell lines confirmed that expression
of PRLR correlated with that of PPARc2, a marker of adipocyte
differentiation, and of UCP1, a marker of brown adipocyte lineage
(Fig. 3D). These findings establish conclusively a direct role for
lactogen signaling in brown adipocyte differentiation.
Figure 3. PRLR is crucial for brown adipocyte differentiation. A) Schematic representation of the null mutation of the PRLR gene by homologous
recombination and gene targeting techniques. Black boxes represent exon 4, 5 and 6. NEO: neomycin gene ; arrows indicate the position of primers
used for PCR. B) PCR genotyping of immortalized brown adipocyte cell lines. C) Morphologic features of wild-type (WT), PRLR KO (KO) and rescued-
PRLR (KO+PRLR) brown adipocytes on day 0 and day 6 of the differentiation program. All cell lines presented fibroblast-like morphology (day 0). Inset:
immunodetection of the SV40 large T antigen in the nucleus of WT and PRLR KO brown adipocytes. WT, KO and KO+PRLR cell lines were cultured in
the presence of 20 nM insulin and 2 nM T3 for 6 days. Light microscopic examination revealed the presence of numerous intracytoplasmic lipid
droplets in the WT brown adipocyte cell line whereas PRLR KO brown adipocytes were unable to accumulate lipid droplets in their cytoplasm.
Overexpression of PRLR in PRLR KO brown adipocytes (KO+PRLR) by stable transfection of a murine PRLR expression vector restores their ability to
differentiate into mature brown adipocytes. D) RT-PCR analyses of PRLR, PPARc2, UCP1 mRNA expression and 18S RNA used as internal control in WT,
KO and rescued-PRLR (KO+PRLR) brown adipocytes. Note the reappearance of a strong PPARc2 expression in rescued-PRLR differentiated brown
adipocytes.
doi:10.1371/journal.pone.0001535.g003
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signaling in BAT
BAT differentiation is under the control of many hormones and
growth factors including insulin and IGF-1. Since IGF-2 has been
previously shown to mediate PRL signaling during mammary
gland morphogenesis [24], we hypothesized that this growth factor
might be a mediator of PRL-induced adipocyte differentiation. To
test this possibility, we first compared the levels of IGF-2 mRNA in
BAT of newborn PRLR KO mice with those in WT mice. IGF-2
transcript levels were 70% lower in BAT of PRLR KO mice than
in BAT of WT littermates (Fig. 4A), indicating that endogenous
IGF-2 gene expression might be under the direct control of PRLR
signaling in brown adipocytes. There was also a 35% reduction in
IGF-2 plasma levels in PRLR KO neonates (Fig. 4B), providing
further evidence that lactogens regulate IGF-2 production during
the fetal and perinatal periods.
Support for a role for PRLR signaling in IGF-2 production was
provided by studies of the effects of PRL on IGF-2 expression in
brown adipocytes in vitro. We first examined the changes in IGF-2
mRNA levels during insulin/T3-induced differentiation of im-
mortalized brown preadipocytes from newborn WT mice. As
shown in Fig. 4C, IGF-2 mRNA levels were significantly higher in
differentiated than in undifferentiated cells; thus brown adipocyte
differentiation is accompanied by a sharp induction of IGF-2
expression. We next compared the levels of IGF-2 mRNA in
immortalized PRLR KO cells and KO+PRLR cells with those in
WT cells. IGF-2 mRNA levels were 75% lower in insulin/T3-
treated PRLR-KO cells than in WT cells on day 6. IGF-2
expression was restored by re-introduction of PRLR into PRLR
KO cells. Finally, we showed that a 3 h-PRL exposure provokes a
2-fold increase in the levels of IGF-2 mRNA in T37i brown
adipocytes (Fig. 4D). Collectively, these findings establish a critical
role for lactogen signaling in brown adipocyte IGF-2 expression.
The mechanisms by which lactogens regulate IGF-2 are
currently unknown. Since PRL is known to mediate most of its
effects through activation of the JAK2/STAT5 pathway, we
determined if the specific JAK2 inhibitor AG490 could blunt the
effect of PRL on IGF-2 expression in T37i cells. As illustrated in
Fig. 4D, we showed that the induction by PRL of IGF-2 mRNA
levels was abolished in the presence of AG490. We next showed
that PRL treatment of differentiated T37i cells induced phos-
phorylation of STAT5 within 15 min (Fig. 4E). Since the IGF-2
gene promoter contains multiple consensus STAT binding sites,
we performed electromobility shift assays with nuclear extracts of
untreated or PRL-treated T37i cells and the STAT response
element located 23184 bp upstream of the transcription initiation
start site of IGF-2 gene (exon 1) (Fig. 4F). Specific oligonucleotide-
protein complexes were detected in PRL-stimulated extracts, a
finding compatible with a model in which PRL regulates IGF-2
transcription through STAT5 activation.
IGF-2 induces brown adipocyte proliferation and
differentiation
Given the effects of lactogen signaling on IGF-2 expression in
BAT, we addressed the role of IGF-2 in preadipocyte proliferation
and adipogenesis. To test whether IGF-2 was able to stimulate
mitogenesis of brown adipocytes, we exposed postconfluent (day 2)
and differentiated (day 7) T37i cells to 20 nM IGF-2 or insulin
(which served as a positive control) and measured
3H-thymidine
incorporation (Fig. 5A). Treatment of proliferating cells with
nanomolar concentrations of IGF-2 induced a 3-fold increase in
3H-thymidine incorporation. IGF-2 stimulated a 2-fold increase in
3H-thymidine incorporation even in differentiated cells, which as
expected had lower basal rates of DNA synthesis than undiffer-
entiated cells. The potency of IGF-2 in these respects was
comparable to that of insulin. Longer exposure to IGF-2 stimulation
induced morphological changes and the appearance of intracyto-
plasmic lipid droplets in T37i cells, demonstrating a major impact of
IGF-2onbrownadipocytedifferentiation(Fig.5B).Quantificationof
Oil Red O staining and measurement of PPARc2m R N Al e v e l s
established that IGF-2 was as or more potent than insulin in
induction of brown adipocyte differentiation (Fig. 5B).
The mechanisms by which IGF-2 stimulates adipogenesis are
currently unknown, but the receptors that mediate most IGF-2
effects in the fetus and placenta, namely insulin receptor form A
(IR-A) and IGF-1 receptor (IGF-1R) [25] were expressed in brown
adipocytes (Supplemental data Fig. S3 and Text S1). In addition,
IGF-2 receptor (IGF-2R), which mediates IGF-2 turnover by
endocytosis, was also detected in brown adipocytes. Since IGF-2
and insulin have been shown to differentially regulate gene
expression through IR-A [26], the respective contributions of
insulin and IGF-2 signaling in brown adipocyte proliferation and
differentiation remain to be established.
IGF-2 can partially reverse the effect of PRLR-
deletion on BAT differentiation
Given the adipogenic effects of IGF-2inT37i cells and the induction
by PRL of IGF-2 expression, we next determined if incubation with
exogenous IGF-2 could reverse the defect in brown adipocyte
differentiation observed in PRLR KO cells. As shown in Fig. 5C,
IGF-2 promoted partial differentiation of PRLR KO cells, with
appearance of foci of mature adipocytes. This finding suggests that
IGF-2 can bypass the absence of PRLR and exert its actions
downstream of PRL signaling. Our findings provide strong evidence
that IGF-2 constitutes one of the major PRL targets in brown
adipocytes and are compatible with an autocrine regulatory loop in
which PRL stimulates endogenous IGF-2 production, which in turn
facilitates activation of adipogenesis in BAT.
DISCUSSION
The lactogens play important roles in carbohydrate metabolism
through effects on pancreatic beta cell mass and insulin production
[27,28] and peripheral insulin sensitivity [29], however their roles
in energy homeostasis and lipid metabolism are poorly understood
[30]. In this study, we demonstrate that lactogen signaling is
essential for brown adipocyte growth and differentiation, thermo-
genic gene expression, and the adaptation to cold stress. Newborn
PRLR KO mice have impaired BAT development as illustrated by
sharp decreases in BAT weight, adipocyte size, and triglyceride
content. The impaired development of BAT is underscored by a
significant decrease in the expression of UCP1, which could be the
consequence of altered BAT development, as illustrated by the
decrease of PPARc2 and its coactivator PGC-1a. It is well
established that PPARc2 is important for the development of BAT
since mouse models with adipose-specific PPARc ablation have
reduced or absent interscapular BAT [31]. Maladaptive responses
to cold have been described in mouse models with deletions in
PGC-1a [32] and PPARc [33]. Moreover, the cold sensitivity of
PRLR KO neonates is also amplified by the reduced expression of
b3Adr, a key effector for UCP1 expression in rodents [23].
Importantly, we observed a major thermoregulatory defect in
PRLR KO animals at birth, highlighting the physiological
importance of PRL signaling in adaptive thermoregulatory
responses to cold challenge. Previous studies [34] demonstrating
a thermogenic effect of PRL in sheep are consistent with our
findings. It is currently unclear if the thermogenic effect of PRL is
Prolactin and Brown Adipocytes
PLoS ONE | www.plosone.org 6 February 2008 | Issue 2 | e1535Figure 4. IGF-2 is a target gene of PRL in brown adipose tissue. A) qPCR analysis of IGF-2 mRNA expression of BAT from newborn mice, results are
expressed as attomol of IGF-2/fmol of 18S, represent mean6SE of 15–16 animals (*** p,0.001). B) Plasma IGF-2 levels. Values in WT (n=16) and in
PRLR KO (n=21) animals represent the mean6SE. (** p,0.01). C) IGF-2 mRNA is expressed as a function of brown adipocyte differentiation. IGF-2
mRNA expression was determined in immortalized WT, PRLR KO, and PRLR-rescued brown adipocytes at day 0 or day 6 of the differentiation
program. Results represent mean6SE of three independent experiments performed in duplicate (*** p,0.001 vs WT at d0). D) Induction by PRL of
IGF-2 mRNA expression in T37i cells. Differentiated T37i cells were incubated overnight with 10% horse serum known to lack prolactin and placental
lactogens, and were stimulated or not by PRL (100 ng/ml) for 3 h. AG490 (100 mM) was added 15 min prior to PRL exposure. IGF-2 mRNA expression
was expressed as mean6SE of 12 independent experiments (* p,0.05). E) STAT5 activation by PRL in T37i cells. Differentiated T37i cells, were
stimulated with 100 ng/ml PRL for 5 and 15 min. Protein lysates were subjected to immunoprecipitation with anti-STAT5 antibody. Samples were
submitted to a SDS-PAGE and western blotting analysis using anti-phosphotyrosine STAT5 and STAT5 antibodies. F) Specific binding to a STAT
response element located in the IGF-2 promoter region. The sequence of STAT-RE is underlined. Nuclear extracts from untreated (8 mg of proteins,
lane 1) and PRL-treated T37i cells (8 mg of proteins, lane 2 or 16 mg of proteins, lane 3) were analyzed for binding to a double-stranded STAT-RE
oligonucleotide. Specific complexes were identified by competition experiments in which 100 ng unlabeled STAT-RE was added (lane 4). Free probe
(lane 5).
doi:10.1371/journal.pone.0001535.g004
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PLoS ONE | www.plosone.org 7 February 2008 | Issue 2 | e1535Figure 5. IGF-2 induces brown adipocyte proliferation and differentiation. A) Undifferentiated (d2) and differentiated (d7) T37i cells were treated
with 20 nM IGF-2 or 20 nM insulin for 8 h. [
3H]-thymidine (1 mCi per well) was then added to cells. Incorporation of [
3H]-thymidine into DNA
represents the mean6SE (three independent experiments performed in quadruplicate) Statistical significance: * p,0.05 and ** p, 0.01. B) T37i cells
were grown in medium supplemented with 10% dextran-coated charcoal serum in the absence (control) or in the presence of 20 nM IGF-2 for 6 days.
A full differentiation switch was observed with IGF-2. (Magnification X 20). Oil Red O staining was performed at d6 in the absence (base) or in the
presence of 20 nM IGF-2, 20 nM insulin or 100 nM IGF-2. Oil Red O stained-cells were solubilized in 10% SDS and the OD520 measured. Results are
mean6SE of three independent experiments. Statistical significance: *p,0.05, **p,0.01 and ***p,0.001, compared to untreated cells. Induction of
PPARc2 mRNA expression in T37i cells treated or not by 20 nM IGF-2 or 20 nM insulin for 7 days. Quantitative real time PCR analysis of PPARc2 mRNA
expression was performed, results expressed as attomol of PPARc2/fmol of 18S, represent mean6SE of three independent experiments performed in
duplicate expressed as fold induction vs undifferentiated cells (*p,0.05 and *** p,0.001). C) PRLR KO preadipocyte cells were grown in medium
supplemented with 10% dextran-coated charcoal serum without or with 20 nM IGF-2 for 6 days where the appearance of fully mature adipocyte foci
were observed (Magnification620).
doi:10.1371/journal.pone.0001535.g005
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PRLR KO adult mice was reported significantly lower than in
WT animals [35].
To assess the impact of lactogen action on brown adipocyte
physiology, we examined the effects of PRLR deletion on brown
adipocyte differentiation in vitro. We showed that immortalized
brown preadipocytes from WT newborn mice differentiated
during exposure to insulin and T3 and expressed the adipogenic
genes PPARc2 and UCP1. In striking contrast, PRLR-deficient
cells failed to differentiate or to express these adipogenic genes
despite long-term treatment with insulin and T3. This finding
indicates that PRLR signaling, like insulin/IGF-1 signaling, is
required for BAT differentiation. Whether or not lactogen action
is also required for white adipose tissue differentiation is unclear,
but PRL induces PPARc and C/EBPb mRNA levels in NIH 3T3
cells [36] and adult female PRLR KO mice have reductions in
abdominal fat mass and decrease in adipocyte numbers [37–39].
This illustrates that beyond the role of PRLR signaling in adaptive
thermogenesis at birth, this pathway may also affect later, white
adipose tissue development and metabolism.
A novel finding of our study is the first demonstration that IGF-
2 serves as a downstream target of lactogen action in the
differentiation of brown adipocytes. We showed that PRLR
deletion is accompanied by reductions in BAT IGF-2 mRNA
levels in vivo and in vitro and that PRL stimulates IGF-2 expression
in brown adipocytes. The latter effect appears to be mediated
through JAK/STAT induction of IGF-2 transcription. We then
showed that IGF-2 stimulates the proliferation and differentiation
of brown adipocytes and reverses partially the defects in brown
adipogenesis observed in PRLR-deficient cells. Even though IGF-
2 only represents one of the molecular PRL targets involved in
BAT growth and differentiation, this illustrates that it can bypass
the absence of PRLR and thereby acts downstream of lactogen
signaling. The molecular mechanisms by which IGF-2 exerts its
actions are not entirely clear, but the receptors that mediate its
effects on placental and fetal growth, namely, the IGF-1R and IR-
A, are expressed in the BAT of newborn mice.
Itisofconsiderableinterestthat plasmaIGF-2levelswerereduced
significantly in PRLR KO mice on the day of birth. This new
observation suggests that lactogenic hormones that circulate in the
fetus in late gestation (in rodents, PL, in humans, PL, PRL, and
growth hormone) may also induce IGF-2 expression in tissues other
than BAT; in theory, these could include the placenta and fetal liver,
adrenal, pancreatic beta cells, and mesenchymal tissues, all of which
express PRLR as well as IGF-2 [4–6,21]. In rodents, the expression
of IGF-2 ceases a few weeks after birth and postnatal murine growth
is IGF-2 independent [21]. In contrast, IGF-2 levels are maintained
throughout development in humans, and IGF-2 levels are variably
decreased in children with growth hormone deficiency [40].
The reductions in BAT IGF-2 expression and plasma IGF-2
concentrations in PRLR KO neonates suggest a model whereby
lactogen action in BAT may be mediated in part through systemic
and/or local IGF-2 production. This model is illustrated in Fig. 6.
Prolactin and/or PL bind to the PRLR of the brown adipocyte
leading to the activation of various signaling pathways including
the MAP kinase (MAPK), phosphatidyl-inositol 3-kinase (PI-3K),
and JAK2/STAT5 pathways and potentiation of IRS signaling
[18]. This results in transcriptional activation of genes including
IGF-2, which is secreted and exerts autocrine/paracrine/endo-
crine effects by binding to IR-A and IGF-1R. Lactogen signaling
thereby promotes cell proliferation, brown adipocyte differentia-
tion and UCP1-mediated thermogenesis.
The finding that IGF-2 reverses only partially the effects of
PRLR deletion suggests that PRL target genes other than IGF-2
might be of major pathophysiological importance. Interestingly,
direct comparison between the predictive anti-adipogenic genes
[41] and the putative PRL target genes identified by microarrays
[24] reveals a strikingly homologous list of candidates. They
include genes related to cell adhesion and extracellular matrix
[42], Wnt signaling pathway [43], cell growth and maintenance
which have been already described to play roles in adipocyte
biology. Additional experiments must be undertaken to ascertain
the involvement of the gene candidates linking PRLR signaling
and adipocyte differentiation.
In summary, our findings reveal the critical role played by
PRLR signaling in brown adipocyte growth and differentiation,
thermogenesis, and the response to cold stress. The mediation of
lactogen action by induction of IGF-2 expression provides a novel
mechanism subserving perinatal adaptation and energy homeo-
stasis. Given the importance of intrauterine programming and
BAT in energy balance, our findings implicate new roles for the
lactogens in the interface between fetal and perinatal development
and metabolic disease.
MATERIALS AND METHODS
PRLR KO mice
All experimental designs and procedures are in agreement with the
guidelines of the animal ethics committee of the Ministe `re de
l’Agriculture (France). WT, and PRLR KO mice on a pure 129
genetic background were generated by heterozygous crossbreeding
[19]. PCR analysis of tail DNA determined the genotypes of the
offspring as described previously [44].
Histological analyses
BAT was isolated from the interscapular space of newborn WT and
PRLR KO mice, fixed in 4% paraformaldehyde, dehydrated and
embeddedinparaffin.Sections(4 mm)weredeparaffinizedinxylene,
rehydrated and stained with hematoxylin eosin. The adipocyte
surfaces were analyzed using a Lucia software on 200 sections per
genotype. Data are mean6SE, for 4 mice per genotype.
Cell extracts, biochemical determinations, and
enzyme assays
BAT was homogenized in 25 mM Tris, pH 7.5, 1 mM EDTA. A
fraction of the homogenate was stored at 280uC. The remaining
fraction was centrifuged at 10,0006g for 10 min at 4uC, and the
supernatant was kept at 280uC until use. Aliquots of homogenates
and supernatants were used to determine protein content.
Triglyceride content was determined on homogenates with
PAP150 triglyceride kit (Biome ´rieux, Marcy L’Etoile, France).
Electron-microscopic analyses
BAT were washed with PBS and fixed for 4 h with 2%
glutaraldehyde (Merck)-2% paraformaldehyde (Sigma) in 0.1 M
phosphate buffer, pH 7.4 (Merck) at room temperature. Tissues
were rinsed in PBS, postfixed with 2% osmium tetroxyde (Uptima,
Montlucon, France) for 30 min, dehydrated in graded ethanol,
and embedded in Durcupan (Fluka, St Quentin, France).
Ultrathin sections were realized and examined with a JEOL
1010 electron microscope.
RT-PCR
Total RNA was extracted from cells with TRIZOL reagent
(InVitrogen, Cergy Pontoise, France) according to the manufacturer’s
recommendations and RNA were thereafter processed for RT-PCR,
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genes analyzed by RT-PCR or by quantitative real time PCR.
Quantitative real time PCR
Specific gene expression was quantified by real time PCR, using an
ABI 7300 Sequence Detector (Applied Biosystems, Foster City, CA).
Briefly, 1 mg of total RNA was treated using DNase I Amplification
Grade procedure (Invitrogen). RNA was thereafter reverse-
transcribed with 200 units of reverse transcriptase using the
Superscript
TM II kit (InVitrogen), then samples were diluted 10-
fold and 1/20
th of the reverse transcription reaction was used for
PCR using the qPCR
TM Mastermix Plus for Sybr
TM Green I
(Eurogentec, Seraing, Belgium), as previously described [45].
Controls without reverse transcriptase and without template were
included to verify that fluorescence was not overestimated by
residual genomic DNA amplification or from primer dimer
Figure 6. Proposed model of regulation of brown adipocyte function by PRL/JAK2/STAT5 /IGF-2 pathway
doi:10.1371/journal.pone.0001535.g006
Table 1. Primer sequences of genes analyzed in PCR, RT-PCR and Real Time PCR
..................................................................................................................................................
Name Accession numbe Amplicon Sense primer Antisense primer
18S X00686 66 bp CCCTGCCCTTTGTACACACC CGATCCGAGGGCCTCACTA
PRLR BC005555 673 bp GAGAAAAACACCTATGAATGTC AGCAGTTCTTCAGACTTGCC
PPARc2 U09138 161 bp GCATCAGGCTTCCACTATGGA AAGGCACTTCTGAAACCGACA
SREBP1 BC056922 152 bp CGGCTGTTGTCTACCATAAGCTG CATAGATCTCTGCCAGTGTTGCC
PGC-1a AF049330 162 bp CCCAGGCAGTAGATCCTCTTCAA CCTTTCGTGCTCATAGGCTTCATA
UCP1 BC012701 150 bp TCACCTTCCCGCTGGACACT GCAGGCAGACCGCTGTACAG
b3AdR NM_013462 150 bp TGCGCACCTTAGGTCTCATTAT AAGGCGGAGTTGGCATAGC
The abbreviations of the genes, their GENBANK or NCBI accession number, the size of the amplicon and 59 to 39nucleotide sequences of the sense and antisense primers
are presented.
doi:10.1371/journal.pone.0001535.t001
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amplification fusion curve to ensure that a single amplicon was
obtained. Quantification was performed by the standard curve
method. Standard curves were generated by serial dilutions of a
linearized plasmid containing the specific amplicon, spanning six
orders of magnitude, yielding a correlation coefficient of at least 0.98
in all experiments. For all experiments, PCR efficiency was close to
1, indicating a doubling of DNA at each PCR cycle, as expected.
Ribosomal 18S RNA was used to normalize for RNA quality,
quantity and RT-efficiency. Relative expression within a given
sample was calculated as the ratio (attomol of specific gene/fmol of
18S). Results are expressed as mean6SE and represent the relative
expression compared to that obtained with control animals or cells.
Kaplan-Meier
All experiments and animal care were performed in accordance
with the animal facility of the Faculty of Medicine Necker. Cold
tolerance was accessed by housing newborn mice at 4uC. When no
sign of tactile stimulation was observed, the mice were sacrificed.
We found that mice up to 6 h were considered without using death
as an end-point.
The survival rate was calculated and expressed according to
Kaplan-Meier representation.
Western blot analyses
Total protein extracts were prepared from BAT isolated from WT
and PRLR KO mice. Tissues were washed twice with ice-cold
PBS and lysed as described in [18], then 2 mg of total protein were
directly submitted to SDS-PAGE. After protein blotting on a
nitrocellulose membrane (Biorad, Marnes-La Coquette, France),
blots were incubated for 1 h at room temperature in 5% milk-Tris
buffer saline/ 0.1% Tween before incubation with the goat anti-
UCP1 (1:3000) (a gift from Pr. D. Ricquier) overnight at 4uC.
After extensive washes, membranes were incubated with a goat
peroxidase-conjugated second antibody (1:2000) for 1 h at room
temperature and proteins were visualized as mentioned above.
After milk saturation, blots were reincubated overnight with rabbit
anti-ERK1/2 (1:1000) (Upstate Biotechnology, Charlottesville,
VA) then incubated with a rabbit peroxidase-conjugated second
antibody (1:10000) for 1 h at room temperature and proteins were
visualized by use of the ECL
+ detection kit.
IGF-2 measurement
IGF-2 was measured by RIA [46] after extraction of IGF binding
proteins on a BioGel P-10 (Bio-Rad, Hercules, CA) column
equilibrated in 1 M acetic acid. The method has been validated
for complete separation of IGFBPs from IGFs in serum and other
biological fluids. The IGF-2 assay uses recombinant human IGF-2
as standard and tracer and a mouse monoclonal antibody. The
intra- and inter-assay coefficients of variation are less than 10%.
The sensitivity of the IGF-2 assay is 50 pg/ml.
Immortalization of WT and PRLR KO preadipocytes
Brown adipocytes and their precursor cells were isolated from
newborn mice by collagenase (1 mg/ml) digestion (Serva, Heidel-
berg, Germany) for 15 min at 37uC as described in [47].
Preadipocytes were thereafter immortalized by stable transfection
with 2.5 mg of HA-TAg SV40 plasmid and 0.5 mg of pEGFP
plasmid (Clontech, Palo Alto, CA) using Lipofectamin Reagent Plus
(InVitrogen). The plasmid HA-TAg SV40, encoded the Large T
Antigen of the simian virus 40 placed under the control of the
proximal promoter of the human mineralocorticoid receptor gene.
This plasmid was originally used as a transgene and allowed to
generate the T37i cell line derived from a hibernoma of a transgenic
mouse [20]. The pEGFP plasmid encoded for the enhanced green
fluorescent protein and for the NeoR gene. Transfected cells were
selected in the presence of 400 mg/ml of geneticin (G418,
InVitrogen). Selective medium was changed 3 times a week for
2 weeks. Foci of cells were isolated using cloning rings and expanded
when possible. PRLR-rescued brown adipocytes were obtained by
transfecting PRLR KO cells with a 2.2 kb mouse PRLR cDNA
previously subcloned into pcDNA 3.1 hygro expression vector
(InVitrogen) after selection with 200 mg/ml hygromycin.
Cell culture
All established cell lines but also T37i brown adipose cell line were
cultured in a complete medium composed of DMEM/HAM’s
F12, 10% fetal calf serum, 2 mM glutamine, 100 IU/ml penicillin,
100 mg/ml streptomycin, and 20 mM HEPES and were grown at
37uC in a humidified atmosphere with 5% CO2. Differentiation
into mature brown adipocytes was achieved by incubating
subconfluent cells with complete medium supplemented with
2 nM triiodothyronine (Sigma, Saint Quentin Fallavier, France)
and 20 nM insulin for 7 days. All products were purchased from
InVitrogen except when stated. Before each hormonal treatment,
human PRL was produced by recombinant technology then
purified as described previously [48]. Human IGF-2 was
purchased from Calbiochem (La Jolla, CA).
Immunodetection of the SV40 large T antigen
Immunodetection was performed using a monoclonal anti-SV40
large T Antigen antibody (Ab-2; Calbiochem). Cells were seeded on
glass slides and fixed with 100% ethanol, rinsed with PBS, and
incubated with a 1:100 dilution of the primary antibody for 45 min
at37uC.After washing, cellswereincubated for 30 minat37uC with
a 1:150 dilution of the biotinylated goat anti-mouse antibody (Tebu,
Le Perray en Yvelines, France) followed with an incubation for
30 min at 37uC with a 1:100 dilution of CY3-streptavidine (Jackson
ImmunoResearch Laboratories, West Grove, PA).
Studies of the activation of STAT5 signaling
pathway
Differentiated T37i cells, starved for 18 h in minimum medium,
were stimulated with 100 ng/ml PRL, during 0, 5 and 15 min;
cells were washed twice with ice-cold PBS and lysed as previously
described [18]. Five hundred mg of total protein were immuno-
precipitated overnight at 4uC with protein A sepharose (Amer-
sham) and the rabbit polyclonal anti-STAT5 (C17 Santa Cruz),
reduced in Laemmli buffer and a 8% acrylamide SDS-PAGE was
performed. Electrotransferred proteins were incubated with
monoclonal anti-phosphotyrosine (1/5000 clone 4G10 Upstate
Biotechnology) followed by incubation with the secondary
antibody: anti-mouse IgG peroxydase-linked (GE Healthcare),
detected with ECL western blotting detection reagent (GE
Healthcare) and exposed to a film (Konica X-ray film AX, Roissy,
France). Blots were stripped by a 30 min-incubation at 50uCi n
62.5 mM Tris-HCl pH 6.8, 2% SDS, 100 mM 2-mercaptoetha-
nol, washed with TBS/0.1% Tween 20 and were incubated with
anti-STAT5 and anti-rabbit IgG peroxydase-linked (GE Health-
care) as secondary antibody.
EMSA
Cells were washed with cold PBS and homogenized in 20 mM
HEPES, pH 7.9, 1.5 mM MgCl2, 600 mM NaCl, 0.2 mM EDTA,
0.5 mM phenylmethylsulfonyl fluoride, 25% glycerol and 0.1%
Prolactin and Brown Adipocytes
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a glass-glass Potter apparatus at 4uC. The homogenates were
centrifuged at 20,0006g for 30 min at 4uC, and the supernatant was
used as whole cell extracts. Gel mobility shift assays were performed
essentially as described in [49]. Purified oligonucleotides were
annealed and labeled with [
32P]-dCTP (GE Healthcare) using the
Klenow fragment of DNA polymerase (Life Technologies, Inc.,
Paisley, UK) to a specific activity of approximately 10
8 cpm/mgo f
DNA. Unlabeled oligonucleotides were used as competitors.
Oligonucleotide sequences were as follows: IGF-2-forward:
59-GCCAGATGTTCTTGGAATGGGACA-39; IGF-2-rev: 59-
GTGTCCCATTCCAAGAACATCTGG-39. Protein-DNA com-
plexes were separated from free DNA by electrophoresis on
nondenaturing 4.5% polyacrylamide gel in 0.25X Tris-borate-
EDTAbufferat200 V for 1 h. Gelswere dried andexposed tox-ray
film at 280uC.
Proliferation assays
T37i cells were cultured in 24-well plates. Post-confluent cells (d2)
and differentiated cells (d7) were rinsed and grown for 12 h in a
serum-free medium (DMEM/HAM’s F12 containing 2 nM T3),
then maintained at 37uC in the same medium for an additional
8 h period, in the absence or presence of 20 nM IGF-2 or insulin,
and 1 mCi/well of [
3H]-Thymidine (GE Healthcare) was added
during the last 2 h. Cells were washed twice with ice-cold PBS and
lysed in 1% SDS. DNA was precipitated by 10% trichloroacetic
acid. The resulting trichloroacetic acid-insoluble pellet was washed
two times with 5% trichloroacetic acid and collected on Whatman
GF/C filters. [
3H]-Thymidine incorporation into DNA was
measured by scintillation counting.
Statistical analyses
All data were prepared for analysis with standard spread sheet
software (Microsoft Excel). Data are expressed as the mean6SE.
Statistical analysis was performed using Student’s t test to
determine significant differences among groups and were
performed using the computer software Prism 4 (GraphPad
Software, San Diego, CA). We performed ANOVA, if statistical
significance (P values *,0.05, **,0.01 and ***,0.001) was
achieved and post-test analysis to account for multiple compar-
isons was done.
SUPPORTING INFORMATION
Figure S1 Lipogenic capacity of brown adipocytes is not
impaired in PRLR KO mice. A) Citrate synthase activity (CS)
and B) Glycerol-3-phosphate dehydrogenase (G3PDH) were
determined in homogenates isolated from the BAT of WT and
KO mice. Results represent mean6SE of 6 animals. NS: not
significant
Found at: doi:10.1371/journal.pone.0001535.s001 (0.18 MB TIF)
Figure S2 COX activity nor COX2 DNA content are altered in
PRLR KO mice. A) Mitochondrial COX2 DNA content was
determined by quantitative real time PCR in homogenates isolated
from the BAT of WT and KO mice. Results, expressed as attomol
of COX2/fmol of 18S, represent mean6SE of 6 animals. NS: not
significant B) Cytochrome c oxidase acitivity (COX, Fig. S2A) was
determined in homogenates isolated from the BAT of WT and
KO mice. Results represent mean6SE of 6 animals. NS: not
significant.
Found at: doi:10.1371/journal.pone.0001535.s002 (0.17 MB TIF)
Figure S3 Differentiated T37i brown adipocytes expressed IGF-
1R, IGF-2R and IR-A. RT-PCR analyses of IGF-1 receptor (IGF-
1R), mannose-6 phosphate receptor (IGF-2R), and Insulin receptor
form A (IR-A) in fully differentiated T37i cells in the presence (+)o r
the absence (-) of the reverse transcriptase. Oligonucleotides were as
followed: IGF-1R-forward 59-CGGTGACTTCTGCTCAAAT-
GC-39; IGF-1R-reverse 59-GAATGGCGGATCTTCACGTAG-
39. IGF-2R-forward 59-CGAGGCCGAAACTCAGATAGA-39;
IGF-2R-reverse 59-AAAACGGATGATGAATGCTGTG-39;I R -
A-forward 59-GCTGGACTGTGGTGGATATTGA-39;I R - A - r e -
verse 59-TCAAGGGATCTTCGCTTTCG-39.
Found at: doi:10.1371/journal.pone.0001535.s003 (0.15 MB TIF)
Text S1
Found at: doi:10.1371/journal.pone.0001535.s004 (0.03 MB
DOC)
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